MedTrace Logo

Plasmafit® Revision Structan® Hip Endoprosthesis Cup

NCT04255966 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2026-05-06

No results posted yet for this study

Summary

The aim of this observational study is to collect clinical and radiological results of the new Plasmafit® Revision Structan® Hip Endoprosthesis Cup in a standard patient population and when used in routine clinical practice.

Conditions

  • Osteolysis
  • Arthroplasty Complications
  • Instability of Prosthetic Joint
  • Degenerative Osteoarthritis
  • Rheumatic Arthritis
  • Fractures, Hip
  • Femoral Head Avascular Necrosis
  • Prosthesis Failure

Interventions

DEVICE

Plasmafit® Revision Structan®

Plasmafit® Revision Structan® Hip Endoprosthesis Cup

Sponsors & Collaborators

  • Aesculap AG

    lead INDUSTRY

Principal Investigators

  • Stefan Landgraeber, Prof. Dr. · University Hospital, Saarland

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-12
Primary Completion
2023-08-16
Completion
2027-06-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04255966 on ClinicalTrials.gov